glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Semaglutides Are Poised to Remake Chronic Disease Care FLOWing with the SemagluTIDE — – FLOW: Kidney outcome results for

Wegovy can be used by adults ages 18-75 who have: A BMI of 30 or above A BMI of 27 or above and you have a weight-related health condition such as: Asthma Cardiovascular disease Depression Fatty liver disease Gallbladder disease High blood pressure History of certain cancers Osteoarthritis or gout PCOS Sleep apnoea You wont be able to take Wegovy if you: Are over 75 Are pregnant or breastfeeding Have liver, kidney or heart failure, an eating disorder or pancreatitis Are taking insulin, sulphonylureas or other weight loss drugs that work in the same way as Wegovy, e.g

Start your intake How Semaglutide Works in a Bypass-Altered Body Semaglutide mimics glucagon-like peptide-1, a natural hormone that signals fullness and slows stomach emptying

(Rest assured, we'll continue to update this as more research comes out)

Let us guide you toward a life of vitality and joy

Plus, studies show that burping is much less common on Saxenda than Wegovy

Especially the face and chin area are more sensitive areas.